GlaxoSmithKline (LSE: GSK) is often pegged as a super-safe income stock due to the rock solid demand for drugs and its 5.8% dividend yield but the fact is this business is in transition and at the moment its payout looks perilously uncovered. However, theres a reason to be optimistic sort of.
Our top analysts have highlightedfive top shares in theFTSE 100in our special free report “5 Shares To Retire On“. To find out the names of the shares and the reasons behind their inclusion, simplyclick hereto view it immediately with no obligations whatsoever.
Owain Bennallackowns shares in GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.